|Bid||9.10 x 800|
|Ask||9.50 x 800|
|Day's Range||9.21 - 9.29|
|52 Week Range||6.66 - 9.40|
|Beta (5Y Monthly)||0.57|
|PE Ratio (TTM)||17.14|
|Forward Dividend & Yield||0.72 (7.78%)|
|Ex-Dividend Date||Nov 25, 2019|
|1y Target Est||N/A|
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn't the intention, these filings to a certain extent level the playing field for ordinary investors. The latest round of 13F […]
By Lisa Thompson NASDAQ:ABDC READ THE FULL ABDC RESEARCH REPORT Alcentra Capital (NASDAQ:ABDC) reported it Q3 2019, which we expect is its last quarter as a public company. It is in the process of being purchased by Crescent Capital BDC for $11.02 per share (the portfolio’s Q2 NAV). After the closing of the merger, Crescent Capital Maryland BDC is expected to apply to have its common stock listed
Alcentra Capital (ABDC) delivered earnings and revenue surprises of -31.58% and -9.48%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Alcentra Capital (ABDC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Today Crescent Capital BDC and Alcentra Capital (ABDC) announced that they have entered into a definitive merger agreement under which Crescent BDC will acquire Alcentra Capital for $11.02 per share (the portfolio’s current NAV). Any final dividend that Alcentra Capital must pay in connection with the closing of the transaction to comply with applicable tax requirements that is in excess of Alcentra Capital’s regular quarterly dividends will reduce the cash consideration to be paid by Crescent BDC on a dollar-for-dollar basis.
By Lisa Thompson NASDAQ:ABDC READ THE FULL ABDC RESEARCH REPORT New management at Alcentra (NASDAQ:ABDC) has made significant progress revamping the portfolio and stabilizing NAV. The company was even ...
Alcentra Capital's (ABDC) reported Q1 2019 earnings and again increased NAV. The new management team continues to execute on its strategy of rotating toward a larger middle market, senior secured debt portfolio. Its goal is to both improve earnings and to decrease the discount of the stock price to NAV.
The New York-based company said it had profit of 15 cents per share. Earnings, adjusted for investment costs, came to 22 cents per share. The results met Wall Street expectations. The average estimate ...
Yesterday, the board of directors of Alcentra Capital (ABDC) announced it had hired Holihan Lockey to formally review strategic alternatives for the company. During this process, the stock has been trading at a significant discount to net asset value.
Alcentra Capital's (ABDC) reported Q4 and full year 2018 earnings. The new management team continues to execute on its strategy of rotating toward a larger middle market, senior secured debt portfolio. Its goal is to both improve earnings and to decrease the discount of the stock price to NAV.
The New York-based company said it had profit of 8 cents per share. Earnings, adjusted for investment costs, were 27 cents per share. The results topped Wall Street expectations. The average estimate of ...